Zinc acetate lozenges may shorten common cold duration by up to 40%: [eLetter]

Research output: Contribution to journalComment/debateScientific

Abstract

The systematic review by Dr. Science et al. has a number of problems. ...
Even though we need further research to find out what the optimal lozenge compositions and treatment strategies are, the great benefit and the minimal adverse effects in the zinc acetate trials gives a strong rationale for physicians to suggest common cold patients to test zinc acetate lozenges (about 80 mg/day of zinc).
Original languageEnglish
JournalCMAJ
Volume184
Issue number10
ISSN0820-3946
Publication statusPublished - 2012
MoE publication typeB1 Journal article

Bibliographical note

Other name of article: Zinc acetate lozenges may shorten common cold duration by up to 40%
Volume:
Proceeding volume:

Fields of Science

  • 3125 Otorhinolaryngology, ophthalmology
  • 317 Pharmacy
  • upper respiratory infections
  • zinc lozenges
  • RANDOMIZED TRIALS
  • Systematic review

Cite this

@article{1c1d6c501eb348d3ba5a78ace4405429,
title = "Zinc acetate lozenges may shorten common cold duration by up to 40{\%}: [eLetter]",
abstract = "The systematic review by Dr. Science et al. has a number of problems. ...Even though we need further research to find out what the optimal lozenge compositions and treatment strategies are, the great benefit and the minimal adverse effects in the zinc acetate trials gives a strong rationale for physicians to suggest common cold patients to test zinc acetate lozenges (about 80 mg/day of zinc).",
keywords = "3125 Otorhinolaryngology, ophthalmology, 317 Pharmacy, upper respiratory infections, zinc lozenges, RANDOMIZED TRIALS, Systematic review",
author = "Harri Hemil{\"a}",
note = "Other name of article: Zinc acetate lozenges may shorten common cold duration by up to 40{\%} Volume: Proceeding volume:",
year = "2012",
language = "English",
volume = "184",
journal = "CMAJ",
issn = "0820-3946",
publisher = "CANADIAN MEDICAL ASSOCIATION",
number = "10",

}

Zinc acetate lozenges may shorten common cold duration by up to 40% : [eLetter]. / Hemilä, Harri.

In: CMAJ, Vol. 184, No. 10, 2012.

Research output: Contribution to journalComment/debateScientific

TY - JOUR

T1 - Zinc acetate lozenges may shorten common cold duration by up to 40%

T2 - [eLetter]

AU - Hemilä, Harri

N1 - Other name of article: Zinc acetate lozenges may shorten common cold duration by up to 40% Volume: Proceeding volume:

PY - 2012

Y1 - 2012

N2 - The systematic review by Dr. Science et al. has a number of problems. ...Even though we need further research to find out what the optimal lozenge compositions and treatment strategies are, the great benefit and the minimal adverse effects in the zinc acetate trials gives a strong rationale for physicians to suggest common cold patients to test zinc acetate lozenges (about 80 mg/day of zinc).

AB - The systematic review by Dr. Science et al. has a number of problems. ...Even though we need further research to find out what the optimal lozenge compositions and treatment strategies are, the great benefit and the minimal adverse effects in the zinc acetate trials gives a strong rationale for physicians to suggest common cold patients to test zinc acetate lozenges (about 80 mg/day of zinc).

KW - 3125 Otorhinolaryngology, ophthalmology

KW - 317 Pharmacy

KW - upper respiratory infections

KW - zinc lozenges

KW - RANDOMIZED TRIALS

KW - Systematic review

M3 - Comment/debate

VL - 184

JO - CMAJ

JF - CMAJ

SN - 0820-3946

IS - 10

ER -